Sanjay Popat and Stephanie Saw
Dec 9, 2024, 20:11
Sanjay Popat: Stephanie Saw discusses Asian subset data from osimertinib
Sanjay Popat, Thoracic Oncologist at The Royal Marsden NHS Foundation Trust, shared on X:
“Stephanie Saw discusses Asian subset data from osimertinib reminding us that osi has not performed as well in Asian subsets as non-Asian subsets, highlighting that perhaps germline EGFR intron 1 polymorphism may contribute to sensitivity.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 3, 2025, 17:26
Sep 3, 2025, 16:34
Sep 3, 2025, 16:23
Sep 3, 2025, 16:06
Sep 3, 2025, 16:04
Sep 3, 2025, 16:03